The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Fasuldil is a new drug with extensive pharmacological effects, which can not only inhibit the activity of free calcium ions in cells, but also inhibit protein kinases.
The global Fasudil market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Fasudil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Fasudil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Fasudil include Asahi Kasei, Grand Pharmaceutical, Sichuan Meida Kangjiale Pharmaceutical, Tianjin Hongri Pharmaceutical, Tianjin Jinyao Pharmaceutical, Shandong Luoxin Pharmaceutical Group, Shanxi Pude Pharmaceutical, Guangzhou Baiyunshan Tianxin Pharmaceutical and Chengdu Yuandong Biological Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Fasudil, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fasudil.
Report Scope
The Fasudil market size, estimations, and forecasts are provided in terms of sales volume (Litre) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fasudil market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fasudil manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Asahi Kasei
Grand Pharmaceutical
Sichuan Meida Kangjiale Pharmaceutical
Tianjin Hongri Pharmaceutical
Tianjin Jinyao Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Shanxi Pude Pharmaceutical
Guangzhou Baiyunshan Tianxin Pharmaceutical
Chengdu Yuandong Biological Pharmaceutical
Jiangsu Disanuo Pharmaceutical
Qilu Pharmaceutical
Wuhan Qirui Pharmaceutical
Xinhua Pharmaceutical
Segment by Type
Interventional Therapy
Intravenous Drip
Segment by Application
Cerebral Vasospasm
Pulmonary Hypertension
Alzheimer's Disease
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fasudil manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fasudil in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Fasuldil is a new drug with extensive pharmacological effects, which can not only inhibit the activity of free calcium ions in cells, but also inhibit protein kinases.
The global Fasudil market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Fasudil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Fasudil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Fasudil include Asahi Kasei, Grand Pharmaceutical, Sichuan Meida Kangjiale Pharmaceutical, Tianjin Hongri Pharmaceutical, Tianjin Jinyao Pharmaceutical, Shandong Luoxin Pharmaceutical Group, Shanxi Pude Pharmaceutical, Guangzhou Baiyunshan Tianxin Pharmaceutical and Chengdu Yuandong Biological Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Fasudil, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fasudil.
Report Scope
The Fasudil market size, estimations, and forecasts are provided in terms of sales volume (Litre) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fasudil market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fasudil manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Asahi Kasei
Grand Pharmaceutical
Sichuan Meida Kangjiale Pharmaceutical
Tianjin Hongri Pharmaceutical
Tianjin Jinyao Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Shanxi Pude Pharmaceutical
Guangzhou Baiyunshan Tianxin Pharmaceutical
Chengdu Yuandong Biological Pharmaceutical
Jiangsu Disanuo Pharmaceutical
Qilu Pharmaceutical
Wuhan Qirui Pharmaceutical
Xinhua Pharmaceutical
Segment by Type
Interventional Therapy
Intravenous Drip
Segment by Application
Cerebral Vasospasm
Pulmonary Hypertension
Alzheimer's Disease
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fasudil manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fasudil in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Fasudil Market Overview
1.1 Product Overview and Scope of Fasudil
1.2 Fasudil Segment by Type
1.2.1 Global Fasudil Market Value Comparison by Type (2024-2030)
1.2.2 Interventional Therapy
1.2.3 Intravenous Drip
1.3 Fasudil Segment by Application
1.3.1 Global Fasudil Market Value by Application: (2024-2030)
1.3.2 Cerebral Vasospasm
1.3.3 Pulmonary Hypertension
1.3.4 Alzheimer's Disease
1.3.5 Other
1.4 Global Fasudil Market Size Estimates and Forecasts
1.4.1 Global Fasudil Revenue 2019-2030
1.4.2 Global Fasudil Sales 2019-2030
1.4.3 Global Fasudil Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Fasudil Market Competition by Manufacturers
2.1 Global Fasudil Sales Market Share by Manufacturers (2019-2024)
2.2 Global Fasudil Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Fasudil Average Price by Manufacturers (2019-2024)
2.4 Global Fasudil Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Fasudil, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Fasudil, Product Type & Application
2.7 Fasudil Market Competitive Situation and Trends
2.7.1 Fasudil Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Fasudil Players Market Share by Revenue
2.7.3 Global Fasudil Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Fasudil Retrospective Market Scenario by Region
3.1 Global Fasudil Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Fasudil Global Fasudil Sales by Region: 2019-2030
3.2.1 Global Fasudil Sales by Region: 2019-2024
3.2.2 Global Fasudil Sales by Region: 2025-2030
3.3 Global Fasudil Global Fasudil Revenue by Region: 2019-2030
3.3.1 Global Fasudil Revenue by Region: 2019-2024
3.3.2 Global Fasudil Revenue by Region: 2025-2030
3.4 North America Fasudil Market Facts & Figures by Country
3.4.1 North America Fasudil Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Fasudil Sales by Country (2019-2030)
3.4.3 North America Fasudil Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Fasudil Market Facts & Figures by Country
3.5.1 Europe Fasudil Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Fasudil Sales by Country (2019-2030)
3.5.3 Europe Fasudil Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Fasudil Market Facts & Figures by Country
3.6.1 Asia Pacific Fasudil Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Fasudil Sales by Country (2019-2030)
3.6.3 Asia Pacific Fasudil Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Fasudil Market Facts & Figures by Country
3.7.1 Latin America Fasudil Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Fasudil Sales by Country (2019-2030)
3.7.3 Latin America Fasudil Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Fasudil Market Facts & Figures by Country
3.8.1 Middle East and Africa Fasudil Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Fasudil Sales by Country (2019-2030)
3.8.3 Middle East and Africa Fasudil Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Fasudil Sales by Type (2019-2030)
4.1.1 Global Fasudil Sales by Type (2019-2024)
4.1.2 Global Fasudil Sales by Type (2025-2030)
4.1.3 Global Fasudil Sales Market Share by Type (2019-2030)
4.2 Global Fasudil Revenue by Type (2019-2030)
4.2.1 Global Fasudil Revenue by Type (2019-2024)
4.2.2 Global Fasudil Revenue by Type (2025-2030)
4.2.3 Global Fasudil Revenue Market Share by Type (2019-2030)
4.3 Global Fasudil Price by Type (2019-2030)
5 Segment by Application
5.1 Global Fasudil Sales by Application (2019-2030)
5.1.1 Global Fasudil Sales by Application (2019-2024)
5.1.2 Global Fasudil Sales by Application (2025-2030)
5.1.3 Global Fasudil Sales Market Share by Application (2019-2030)
5.2 Global Fasudil Revenue by Application (2019-2030)
5.2.1 Global Fasudil Revenue by Application (2019-2024)
5.2.2 Global Fasudil Revenue by Application (2025-2030)
5.2.3 Global Fasudil Revenue Market Share by Application (2019-2030)
5.3 Global Fasudil Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Asahi Kasei
6.1.1 Asahi Kasei Corporation Information
6.1.2 Asahi Kasei Description and Business Overview
6.1.3 Asahi Kasei Fasudil Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Asahi Kasei Fasudil Product Portfolio
6.1.5 Asahi Kasei Recent Developments/Updates
6.2 Grand Pharmaceutical
6.2.1 Grand Pharmaceutical Corporation Information
6.2.2 Grand Pharmaceutical Description and Business Overview
6.2.3 Grand Pharmaceutical Fasudil Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Grand Pharmaceutical Fasudil Product Portfolio
6.2.5 Grand Pharmaceutical Recent Developments/Updates
6.3 Sichuan Meida Kangjiale Pharmaceutical
6.3.1 Sichuan Meida Kangjiale Pharmaceutical Corporation Information
6.3.2 Sichuan Meida Kangjiale Pharmaceutical Description and Business Overview
6.3.3 Sichuan Meida Kangjiale Pharmaceutical Fasudil Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sichuan Meida Kangjiale Pharmaceutical Fasudil Product Portfolio
6.3.5 Sichuan Meida Kangjiale Pharmaceutical Recent Developments/Updates
6.4 Tianjin Hongri Pharmaceutical
6.4.1 Tianjin Hongri Pharmaceutical Corporation Information
6.4.2 Tianjin Hongri Pharmaceutical Description and Business Overview
6.4.3 Tianjin Hongri Pharmaceutical Fasudil Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Tianjin Hongri Pharmaceutical Fasudil Product Portfolio
6.4.5 Tianjin Hongri Pharmaceutical Recent Developments/Updates
6.5 Tianjin Jinyao Pharmaceutical
6.5.1 Tianjin Jinyao Pharmaceutical Corporation Information
6.5.2 Tianjin Jinyao Pharmaceutical Description and Business Overview
6.5.3 Tianjin Jinyao Pharmaceutical Fasudil Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Tianjin Jinyao Pharmaceutical Fasudil Product Portfolio
6.5.5 Tianjin Jinyao Pharmaceutical Recent Developments/Updates
6.6 Shandong Luoxin Pharmaceutical Group
6.6.1 Shandong Luoxin Pharmaceutical Group Corporation Information
6.6.2 Shandong Luoxin Pharmaceutical Group Description and Business Overview
6.6.3 Shandong Luoxin Pharmaceutical Group Fasudil Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Shandong Luoxin Pharmaceutical Group Fasudil Product Portfolio
6.6.5 Shandong Luoxin Pharmaceutical Group Recent Developments/Updates
6.7 Shanxi Pude Pharmaceutical
6.6.1 Shanxi Pude Pharmaceutical Corporation Information
6.6.2 Shanxi Pude Pharmaceutical Description and Business Overview
6.6.3 Shanxi Pude Pharmaceutical Fasudil Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Shanxi Pude Pharmaceutical Fasudil Product Portfolio
6.7.5 Shanxi Pude Pharmaceutical Recent Developments/Updates
6.8 Guangzhou Baiyunshan Tianxin Pharmaceutical
6.8.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Corporation Information
6.8.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Description and Business Overview
6.8.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Fasudil Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Fasudil Product Portfolio
6.8.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Recent Developments/Updates
6.9 Chengdu Yuandong Biological Pharmaceutical
6.9.1 Chengdu Yuandong Biological Pharmaceutical Corporation Information
6.9.2 Chengdu Yuandong Biological Pharmaceutical Description and Business Overview
6.9.3 Chengdu Yuandong Biological Pharmaceutical Fasudil Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Chengdu Yuandong Biological Pharmaceutical Fasudil Product Portfolio
6.9.5 Chengdu Yuandong Biological Pharmaceutical Recent Developments/Updates
6.10 Jiangsu Disanuo Pharmaceutical
6.10.1 Jiangsu Disanuo Pharmaceutical Corporation Information
6.10.2 Jiangsu Disanuo Pharmaceutical Description and Business Overview
6.10.3 Jiangsu Disanuo Pharmaceutical Fasudil Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Jiangsu Disanuo Pharmaceutical Fasudil Product Portfolio
6.10.5 Jiangsu Disanuo Pharmaceutical Recent Developments/Updates
6.11 Qilu Pharmaceutical
6.11.1 Qilu Pharmaceutical Corporation Information
6.11.2 Qilu Pharmaceutical Fasudil Description and Business Overview
6.11.3 Qilu Pharmaceutical Fasudil Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Qilu Pharmaceutical Fasudil Product Portfolio
6.11.5 Qilu Pharmaceutical Recent Developments/Updates
6.12 Wuhan Qirui Pharmaceutical
6.12.1 Wuhan Qirui Pharmaceutical Corporation Information
6.12.2 Wuhan Qirui Pharmaceutical Fasudil Description and Business Overview
6.12.3 Wuhan Qirui Pharmaceutical Fasudil Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Wuhan Qirui Pharmaceutical Fasudil Product Portfolio
6.12.5 Wuhan Qirui Pharmaceutical Recent Developments/Updates
6.13 Xinhua Pharmaceutical
6.13.1 Xinhua Pharmaceutical Corporation Information
6.13.2 Xinhua Pharmaceutical Fasudil Description and Business Overview
6.13.3 Xinhua Pharmaceutical Fasudil Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Xinhua Pharmaceutical Fasudil Product Portfolio
6.13.5 Xinhua Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Fasudil Industry Chain Analysis
7.2 Fasudil Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Fasudil Production Mode & Process
7.4 Fasudil Sales and Marketing
7.4.1 Fasudil Sales Channels
7.4.2 Fasudil Distributors
7.5 Fasudil Customers
8 Fasudil Market Dynamics
8.1 Fasudil Industry Trends
8.2 Fasudil Market Drivers
8.3 Fasudil Market Challenges
8.4 Fasudil Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Fasudil Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Fasudil Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Fasudil Market Competitive Situation by Manufacturers in 2023
Table 4. Global Fasudil Sales (Litre) of Key Manufacturers (2019-2024)
Table 5. Global Fasudil Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Fasudil Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Fasudil Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Fasudil Average Price (US$/Litre) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Fasudil, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Fasudil, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Fasudil, Product Type & Application
Table 12. Global Key Manufacturers of Fasudil, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Fasudil by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fasudil as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Fasudil Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Fasudil Sales by Region (2019-2024) & (Litre)
Table 18. Global Fasudil Sales Market Share by Region (2019-2024)
Table 19. Global Fasudil Sales by Region (2025-2030) & (Litre)
Table 20. Global Fasudil Sales Market Share by Region (2025-2030)
Table 21. Global Fasudil Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Fasudil Revenue Market Share by Region (2019-2024)
Table 23. Global Fasudil Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Fasudil Revenue Market Share by Region (2025-2030)
Table 25. North America Fasudil Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Fasudil Sales by Country (2019-2024) & (Litre)
Table 27. North America Fasudil Sales by Country (2025-2030) & (Litre)
Table 28. North America Fasudil Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Fasudil Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Fasudil Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Fasudil Sales by Country (2019-2024) & (Litre)
Table 32. Europe Fasudil Sales by Country (2025-2030) & (Litre)
Table 33. Europe Fasudil Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Fasudil Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Fasudil Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Fasudil Sales by Region (2019-2024) & (Litre)
Table 37. Asia Pacific Fasudil Sales by Region (2025-2030) & (Litre)
Table 38. Asia Pacific Fasudil Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Fasudil Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Fasudil Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Fasudil Sales by Country (2019-2024) & (Litre)
Table 42. Latin America Fasudil Sales by Country (2025-2030) & (Litre)
Table 43. Latin America Fasudil Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Fasudil Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Fasudil Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Fasudil Sales by Country (2019-2024) & (Litre)
Table 47. Middle East & Africa Fasudil Sales by Country (2025-2030) & (Litre)
Table 48. Middle East & Africa Fasudil Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Fasudil Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Fasudil Sales (Litre) by Type (2019-2024)
Table 51. Global Fasudil Sales (Litre) by Type (2025-2030)
Table 52. Global Fasudil Sales Market Share by Type (2019-2024)
Table 53. Global Fasudil Sales Market Share by Type (2025-2030)
Table 54. Global Fasudil Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Fasudil Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Fasudil Revenue Market Share by Type (2019-2024)
Table 57. Global Fasudil Revenue Market Share by Type (2025-2030)
Table 58. Global Fasudil Price (US$/Litre) by Type (2019-2024)
Table 59. Global Fasudil Price (US$/Litre) by Type (2025-2030)
Table 60. Global Fasudil Sales (Litre) by Application (2019-2024)
Table 61. Global Fasudil Sales (Litre) by Application (2025-2030)
Table 62. Global Fasudil Sales Market Share by Application (2019-2024)
Table 63. Global Fasudil Sales Market Share by Application (2025-2030)
Table 64. Global Fasudil Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Fasudil Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Fasudil Revenue Market Share by Application (2019-2024)
Table 67. Global Fasudil Revenue Market Share by Application (2025-2030)
Table 68. Global Fasudil Price (US$/Litre) by Application (2019-2024)
Table 69. Global Fasudil Price (US$/Litre) by Application (2025-2030)
Table 70. Asahi Kasei Corporation Information
Table 71. Asahi Kasei Description and Business Overview
Table 72. Asahi Kasei Fasudil Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2019-2024)
Table 73. Asahi Kasei Fasudil Product
Table 74. Asahi Kasei Recent Developments/Updates
Table 75. Grand Pharmaceutical Corporation Information
Table 76. Grand Pharmaceutical Description and Business Overview
Table 77. Grand Pharmaceutical Fasudil Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2019-2024)
Table 78. Grand Pharmaceutical Fasudil Product
Table 79. Grand Pharmaceutical Recent Developments/Updates
Table 80. Sichuan Meida Kangjiale Pharmaceutical Corporation Information
Table 81. Sichuan Meida Kangjiale Pharmaceutical Description and Business Overview
Table 82. Sichuan Meida Kangjiale Pharmaceutical Fasudil Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2019-2024)
Table 83. Sichuan Meida Kangjiale Pharmaceutical Fasudil Product
Table 84. Sichuan Meida Kangjiale Pharmaceutical Recent Developments/Updates
Table 85. Tianjin Hongri Pharmaceutical Corporation Information
Table 86. Tianjin Hongri Pharmaceutical Description and Business Overview
Table 87. Tianjin Hongri Pharmaceutical Fasudil Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2019-2024)
Table 88. Tianjin Hongri Pharmaceutical Fasudil Product
Table 89. Tianjin Hongri Pharmaceutical Recent Developments/Updates
Table 90. Tianjin Jinyao Pharmaceutical Corporation Information
Table 91. Tianjin Jinyao Pharmaceutical Description and Business Overview
Table 92. Tianjin Jinyao Pharmaceutical Fasudil Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2019-2024)
Table 93. Tianjin Jinyao Pharmaceutical Fasudil Product
Table 94. Tianjin Jinyao Pharmaceutical Recent Developments/Updates
Table 95. Shandong Luoxin Pharmaceutical Group Corporation Information
Table 96. Shandong Luoxin Pharmaceutical Group Description and Business Overview
Table 97. Shandong Luoxin Pharmaceutical Group Fasudil Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2019-2024)
Table 98. Shandong Luoxin Pharmaceutical Group Fasudil Product
Table 99. Shandong Luoxin Pharmaceutical Group Recent Developments/Updates
Table 100. Shanxi Pude Pharmaceutical Corporation Information
Table 101. Shanxi Pude Pharmaceutical Description and Business Overview
Table 102. Shanxi Pude Pharmaceutical Fasudil Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2019-2024)
Table 103. Shanxi Pude Pharmaceutical Fasudil Product
Table 104. Shanxi Pude Pharmaceutical Recent Developments/Updates
Table 105. Guangzhou Baiyunshan Tianxin Pharmaceutical Corporation Information
Table 106. Guangzhou Baiyunshan Tianxin Pharmaceutical Description and Business Overview
Table 107. Guangzhou Baiyunshan Tianxin Pharmaceutical Fasudil Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2019-2024)
Table 108. Guangzhou Baiyunshan Tianxin Pharmaceutical Fasudil Product
Table 109. Guangzhou Baiyunshan Tianxin Pharmaceutical Recent Developments/Updates
Table 110. Chengdu Yuandong Biological Pharmaceutical Corporation Information
Table 111. Chengdu Yuandong Biological Pharmaceutical Description and Business Overview
Table 112. Chengdu Yuandong Biological Pharmaceutical Fasudil Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2019-2024)
Table 113. Chengdu Yuandong Biological Pharmaceutical Fasudil Product
Table 114. Chengdu Yuandong Biological Pharmaceutical Recent Developments/Updates
Table 115. Jiangsu Disanuo Pharmaceutical Corporation Information
Table 116. Jiangsu Disanuo Pharmaceutical Description and Business Overview
Table 117. Jiangsu Disanuo Pharmaceutical Fasudil Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2019-2024)
Table 118. Jiangsu Disanuo Pharmaceutical Fasudil Product
Table 119. Jiangsu Disanuo Pharmaceutical Recent Developments/Updates
Table 120. Qilu Pharmaceutical Corporation Information
Table 121. Qilu Pharmaceutical Description and Business Overview
Table 122. Qilu Pharmaceutical Fasudil Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2019-2024)
Table 123. Qilu Pharmaceutical Fasudil Product
Table 124. Qilu Pharmaceutical Recent Developments/Updates
Table 125. Wuhan Qirui Pharmaceutical Corporation Information
Table 126. Wuhan Qirui Pharmaceutical Description and Business Overview
Table 127. Wuhan Qirui Pharmaceutical Fasudil Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2019-2024)
Table 128. Wuhan Qirui Pharmaceutical Fasudil Product
Table 129. Wuhan Qirui Pharmaceutical Recent Developments/Updates
Table 130. Xinhua Pharmaceutical Corporation Information
Table 131. Xinhua Pharmaceutical Description and Business Overview
Table 132. Xinhua Pharmaceutical Fasudil Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2019-2024)
Table 133. Xinhua Pharmaceutical Fasudil Product
Table 134. Xinhua Pharmaceutical Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Fasudil Distributors List
Table 138. Fasudil Customers List
Table 139. Fasudil Market Trends
Table 140. Fasudil Market Drivers
Table 141. Fasudil Market Challenges
Table 142. Fasudil Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Fasudil
Figure 2. Global Fasudil Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Fasudil Market Share by Type in 2023 & 2030
Figure 4. Interventional Therapy Product Picture
Figure 5. Intravenous Drip Product Picture
Figure 6. Global Fasudil Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Fasudil Market Share by Application in 2023 & 2030
Figure 8. Cerebral Vasospasm
Figure 9. Pulmonary Hypertension
Figure 10. Alzheimer's Disease
Figure 11. Other
Figure 12. Global Fasudil Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Fasudil Market Size (2019-2030) & (US$ Million)
Figure 14. Global Fasudil Sales (2019-2030) & (Litre)
Figure 15. Global Fasudil Average Price (US$/Litre) & (2019-2030)
Figure 16. Fasudil Report Years Considered
Figure 17. Fasudil Sales Share by Manufacturers in 2023
Figure 18. Global Fasudil Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Fasudil Players: Market Share by Revenue in 2023
Figure 20. Fasudil Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Fasudil Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Fasudil Sales Market Share by Country (2019-2030)
Figure 23. North America Fasudil Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Fasudil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Fasudil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Fasudil Sales Market Share by Country (2019-2030)
Figure 27. Europe Fasudil Revenue Market Share by Country (2019-2030)
Figure 28. Germany Fasudil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Fasudil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Fasudil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Fasudil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Fasudil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Fasudil Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Fasudil Revenue Market Share by Region (2019-2030)
Figure 35. China Fasudil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Fasudil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Fasudil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Fasudil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Fasudil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Fasudil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Fasudil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Fasudil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Fasudil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Fasudil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Fasudil Sales Market Share by Country (2019-2030)
Figure 46. Latin America Fasudil Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Fasudil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Fasudil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Fasudil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Fasudil Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Fasudil Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Fasudil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Fasudil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Fasudil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Fasudil by Type (2019-2030)
Figure 56. Global Revenue Market Share of Fasudil by Type (2019-2030)
Figure 57. Global Fasudil Price (US$/Litre) by Type (2019-2030)
Figure 58. Global Sales Market Share of Fasudil by Application (2019-2030)
Figure 59. Global Revenue Market Share of Fasudil by Application (2019-2030)
Figure 60. Global Fasudil Price (US$/Litre) by Application (2019-2030)
Figure 61. Fasudil Value Chain
Figure 62. Fasudil Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
